Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics
Cells · 2024
DOI: 10.3390/cells13161346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Michela Corsini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Cell Membrane, Mutation, Vascular Endothelial Growth Factor Receptor-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC, Cariplo Foundation, PNRR M4C2-Investimento 1.4-CN00000041 finanziato dall'Unione Europea-NextGenerationEU.
Abstract (Originalsprache)
Background
Recently, the substitution R1051Q in VEGFR2 has been described as a cancer-associated “gain of function” mutation. VEGFR2R1051Q phosphorylation is ligand-independent and enhances the activation of intracellular pathways and cell growth both in vitro and in vivo. In cancer, this mutation is found in heterozygosity, suggesting that an interaction between VEGFR2R1051Q and VEGFR2WT may occur and could explain, at least in part, how VEGFR2R1051Q acts to promote VEGFR2 signaling. Despite this, the biochemical/biophysical mechanism of the activation of VEGFR2R1051Q remains poorly understood. On these bases, the aim of our study is to address how VEGFR2R1051Q influences the biophysical behavior (dimerization and membrane dynamics) of the co-expressed VEGFR2WT.
Methods
We employed quantitative FLIM/FRET and FRAP imaging techniques using CHO cells co-transfected with the two forms of VEGFR2 to mimic heterozygosity.
Results
Membrane protein biotinylation reveals that VEGFR2WT is more exposed on the cell membrane with respect to VEGFR2R1051Q. The imaging analyses show the ability of VEGFR2WT to form heterodimers with VEGFR2R1051Q and this interaction alters its membrane dynamics. Indeed, when the co-expression of VEGFR2WT/VEGFR2R1051Q occurs, VEGFR2WT shows reduced lateral motility and a minor pool of mobile fraction.
Conclusions
This study demonstrates that active VEGFR2R1051Q can affect the membrane behavior of the VEGFR2WT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
- CN3 "Sviluppo di Terapia Genica e Farmaci con Tecnologia ad RNA", 25123 Brescia, Italy.
- CIB Consorzio Interuniversitario per le Biotecnologie, 25123 Brescia, Italy.
ORCID-Profile: Michela Corsini, Cosetta Ravelli, Elisabetta Grillo, Stefania Mitola
Förderung
- AIRC
- Cariplo Foundation
- PNRR M4C2-Investimento 1.4-CN00000041 finanziato dall'Unione Europea-NextGenerationEU
- Associazione Italiana Ricerca sul Cancro
- PNRR M4C2-Investimento 1.4-CN00000041 finanziato dall’Unione Europea–NextGenerationEU
Zitieren
APA
Corsini, M., Ravelli, C., Grillo, E., Domenichini, M., & Mitola, S. (2024). Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics. Cells. https://doi.org/10.3390/cells13161346
Vancouver
Corsini M, Ravelli C, Grillo E, Domenichini M, Mitola S. Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics. Cells. 2024. doi:10.3390/cells13161346
BibTeX
@article{Corsini2024,
author = {Corsini, Michela and Ravelli, Cosetta and Grillo, Elisabetta and Domenichini, Mattia and Mitola, Stefania},
title = {Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13161346}
}
EUVIMED